Home › Uterine Cancer
Uterine Cancer clinical trials recruiting in the U.S.
29 studies for Uterine Cancer are recruiting participants at sites across the United States.
Uterine cancer is a cancer that forms in tissues of the uterus. It is more likely to happen after menopause. There are things you can do that may help lower your risk.
Cities with the most studies
- Houston, TX8 studies
- Columbus, OH6 studies
- New York City, NY6 studies
- Austin, TX5 studies
- Boston, MA5 studies
- Miami, FL5 studies
- Philadelphia, PA5 studies
- Pittsburgh, PA4 studies
- Nashville, TN4 studies
- West Palm Beach, FL4 studies
- Providence, RI4 studies
- St. Louis, MO4 studies
- Orlando, FL4 studies
- Chicago, IL4 studies
- Baltimore, MD4 studies
- St. Petersburg, FL3 studies
- Oklahoma City, OK3 studies
- Camden, NJ3 studies
- Portland, OR3 studies
- Eugene, OR3 studies
- Seattle, WA3 studies
- Dallas, TX3 studies
- San Diego, CA3 studies
- Fort Worth, TX3 studies
- Arlington, VA3 studies
- Cape Coral, FL3 studies
- Birmingham, AL3 studies
- Miami Beach, FL3 studies
- Baldwin Park, CA3 studies
- Minneapolis, MN3 studies
- Indianapolis, IN3 studies
By state
- Alabama3 studies
- Arizona3 studies
- California9 studies
- Florida7 studies
- Georgia3 studies
- Illinois5 studies
- Indiana3 studies
- Maryland5 studies
- Massachusetts5 studies
- Michigan3 studies
- Minnesota5 studies
- Missouri5 studies
- New Jersey6 studies
- New York8 studies
- North Carolina4 studies
- Ohio6 studies
- Oklahoma4 studies
- Oregon4 studies
- Pennsylvania7 studies
- Rhode Island4 studies
- Tennessee4 studies
- Texas10 studies
- Virginia4 studies
- Washington3 studies
Recently updated studies
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT04038619PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT05758688Sentinel Node Biopsy in Endometrial Cancer
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 15, 2026 · NCT04073706DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 3, 2026 · NCT06989112Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RecruitingObservational study
Ages 18 to 50 · Women · Updated Sep 2, 2026 · NCT06904365Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
RecruitingPhase 2
Ages 18 and older · Women · Updated Aug 27, 2026 · NCT06492070PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT04329494Investigations of Reproductive Cancers in Women
RecruitingObservational study
Ages 45 to 100 · Women · Updated Aug 17, 2026 · NCT06527157Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
RecruitingPhase 1/2
Ages 18 and older · Women · Updated Aug 13, 2026 · NCT06040970Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366Hypofractionated Radiochemotherapy
RecruitingPhase 2
Ages 18 to 120 · Women · Updated Jul 30, 2026 · NCT06331468Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT07106359[18F]FES PET/.CT in Uterine Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Jun 5, 2026 · NCT05916196Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Recruiting
Ages 60 and older · Women · Updated May 29, 2026 · NCT05743517Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
RecruitingObservational study
Ages 18 and older · Women · Updated May 6, 2026 · NCT05049538Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
RecruitingPhase 1/2
Ages 18 and older · Women · Updated Apr 15, 2026 · NCT05559879Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Recruiting
Ages 18 and older · Women · Updated Mar 24, 2026 · NCT05990426Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
RecruitingObservational study
Ages 18 to 90 · Women · Updated Mar 6, 2026 · NCT05977621Azenosertib in Uterine Serous Carcinoma: Biomarker Study
RecruitingPhase 2
Ages 18 and older · Women · Updated Mar 2, 2026 · NCT06369155With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Recruiting
Ages 21 and older · Women · Updated Feb 25, 2026 · NCT05721976Sample Collection for Ongoing Research and Product Evaluation Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 15, 2026 · NCT07318051Image-Guided Gynecologic Brachytherapy
Recruiting
Ages 18 to 100 · Women · Updated Dec 18, 2025 · NCT02993900From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.